|
市場調査レポート
商品コード
1298803
皮膚治療薬市場:皮膚科疾患別、投与経路別、流通チャネル別、地域別2023-2028年Dermatological Drugs Market by Dermatological Diseases, Route of Administration, Distribution Channel, and Region 2023-2028 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。 |
皮膚治療薬市場:皮膚科疾患別、投与経路別、流通チャネル別、地域別2023-2028年 |
出版日: 2023年06月14日
発行: IMARC
ページ情報: 英文 140 Pages
納期: 2~3営業日
|
皮膚治療薬の世界市場規模は2022年に215億8,000万米ドルに達しました。今後、IMARC Groupは、2023年から2028年にかけて10.25%の成長率(CAGR)を示し、2028年までに391億1,000万米ドルに達すると予測しています。皮膚疾患の有病率の上昇、コスメシューティカルズに対する需要の増加、皮膚の健康に対する個人の意識の高まりは、市場を牽引する主な要因のひとつです。
皮膚治療薬は、にきび、乾癬、湿疹、酒さ、皮膚がん、真菌感染症、皮膚、毛髪、爪に影響を及ぼすその他の疾患など、さまざまな皮膚疾患の治療に使用される医薬品です。これらの薬剤は、治療する皮膚疾患の種類に応じて、局所投与、経口投与、または注射によって使用されます。クリーム、軟膏、ジェル、スプレーなどの皮膚外用薬は、皮膚に直接塗布します。にきびや湿疹などの局所的な皮膚疾患の治療に最もよく使用されます。一方、全身性の皮膚治療薬は経口または注射で服用するもので、皮膚疾患の根本的な原因をターゲットとして作用します。これらの薬剤は、乾癬のような重度または広範囲の皮膚疾患の治療に使用されることが多いです。これらの製品は化粧品と医薬品の両方の特性を持ち、皮膚の全体的な健康と見た目を改善するように設計されています。さらに、皮膚科用医薬品は皮膚科医や皮膚の健康に精通した医療専門家によって処方されるため、世界中で需要が拡大しています。
市場は主に、乾癬、湿疹、にきび、酒さ、皮膚がんなどの皮膚疾患の有病率の増加が牽引しています。さらに、このような病気にかかりやすい老年人口が増加していることも、成長を促す大きな要因となっています。これに加えて、皮膚の全体的な健康と外観を改善するために、医薬品的特性を持つ化粧品であるコスメシューティカルズを広く採用する個人も増えています。これは、健康な皮膚を維持することの重要性に対する個人の意識の高まりと相まって、市場の成長にプラスの影響を与えています。患者は現在、皮膚疾患の治療を求める意識が高まっており、皮膚科用医薬品の全体的な需要増につながっています。さらに、経皮パッチ、ナノテクノロジー、マイクロニードルなどのドラッグデリバリーシステムにおける様々な技術進歩が、皮膚科薬市場の成長を促進しています。これらの新しいドラッグデリバリーシステムは、薬剤の効能を向上させ、患者のコンプライアンスを高める。さらに、消費者の可処分所得の増加、一般用医薬品(OTC)の人気の高まり、利用可能な治療オプションに関する意識の高まりは、世界中で良好な市場見通しを生み出しているその他の要因の一部です。
The global dermatological drugs market size reached US$ 21.58 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 39.11 Billion by 2028, exhibiting a growth rate (CAGR) of 10.25% during 2023-2028. The rising prevalence of skin disorders, the increasing demand for cosmeceuticals, and the growing awareness among individuals about skin health represent some of the key factors driving the market.
Dermatological drugs are medications that are used to treat various skin conditions, including acne, psoriasis, eczema, rosacea, skin cancer, fungal infections, and other disorders affecting the skin, hair, and nails. These drugs can be applied topically, orally, or by injection, depending on the type of skin condition being treated. Topical dermatological drugs, including creams, ointments, gels, and sprays, are directly applied to the skin. They are most commonly used to treat localized skin conditions, such as acne or eczema. On the other hand, systemic dermatological drugs are taken orally or by injection and work by targeting the underlying cause of a skin condition. These drugs are often used to treat severe or widespread skin conditions, such as psoriasis. These products have both cosmetic and pharmaceutical properties, and they are designed to improve the overall health and appearance of the skin. Moreover, dermatological drugs are prescribed by dermatologists or other healthcare professionals with expertise in skin health, which is escalating their demand across the globe.
The market is primarily driven by the increasing prevalence of skin disorders such as psoriasis, eczema, acne, rosacea, and skin cancer. In addition, the rising geriatric population that is more susceptible to such ailments represents another major growth-inducing factor. Besides this, individuals are widely adopting cosmeceuticals, which are cosmetic products with pharmaceutical properties to improve the overall health and appearance of the skin. This, coupled with the growing awareness among individuals about the importance of maintaining healthy skin, is positively influencing the market growth. Patients are now more aware of seeking treatment for skin conditions, leading to an increase in the overall demand for dermatological drugs. Moreover, various technological advancements in drug delivery systems, such as transdermal patches, nanotechnology, and microneedles, are driving the growth of the dermatological drugs market. These new drug delivery systems improve the efficacy of drugs and enhance patient compliance. Furthermore, the rising disposable incomes of consumers, the growing popularity of over the counter (OTC) drugs and the increasing awareness regarding the available treatment options are some of the other factors creating a favorable market outlook across the globe.
IMARC Group provides an analysis of the key trends in each segment of the global dermatological drugs market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on dermatological diseases, route of administration, and distribution channel.
Acne
Dermatitis
Psoriasis
Skin Cancer
Others
The report has provided a detailed breakup and analysis of the dermatological drugs market based on the dermatological diseases. This includes acne, dermatitis, psoriasis, skin cancer, and others. According to the report, psoriasis represented the largest segment.
Oral
Parenteral
Topical
A detailed breakup and analysis of the dermatological drugs market based on the route of administration has also been provided in the report. This includes oral, parenteral, and topical. According to the report, parenteral accounted for the largest market share.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The report has provided a detailed breakup and analysis of the dermatological drugs market based on the distribution channel. This includes hospital pharmacies, retail pharmacies, and online pharmacies. According to the report, hospital pharmacies represented the largest segment.
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for dermatological drugs. Some of the factors driving the North America dermatological drugs market included the growing prevalence of skin conditions, the rising awareness regarding appearance, and the escalating demand for cosmeceuticals.
The report has also provided a comprehensive analysis of the competitive landscape in the global dermatological drugs market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include AbbVie Inc., Amgen Inc., Bausch Health Companies Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, GSK plc, LEO Pharma A/S (LEO Holding A/S), Novartis AG, Pfizer Inc., Sanofi S.A., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.